In October, the EMA announced that it was looking to improve the efficiency of its approval process for new medicines in the European Union (EU). The stated aim for the agency was to better manage ...
Pharmaceutical Technology on MSN2d
Unsafe and unregulated cell therapies being sold in EuropeThe EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...
The FDA has granted approval to an act of compassionate use treatment with the anti-cancer drug Namodenoson for a patient ...
The TxGemma models are – as the name suggests – an offshoot of Google's Gemma family of open-source, generative AI (GenAI) ...
Novo Nordisk’s Wegovy is about to enter the Irish market but people will have to pay for it from their own pocket - for now ...
Under IVDR, clear and specific IVD intended use criteria are required and introduce significant challenges for manufacturers ...
HTA as described by the HTA Regulation is the multidisciplinary scientific evidence-based process that allows to determine the relative effectiveness of new or existing health technologies. HTA is a ...
allAfrica.com on MSN22h
Africa: A Jab That Could Protect Against HIV for a Year At a Time, and Other Highlights From Major ConferenceA single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...
The global industry was valued at US$ 527.5 Mn in 2024 and is projected to exceed US$ 771.0 Mn by 2035, growing at a CAGR of ...
Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the "Company” or "Eagle”) today announced that its Board of Directors (the ...
Q4 2024 Earnings Call Transcript March 17, 2025 Protalix BioTherapeutics, Inc. beats earnings expectations. Reported EPS is $0.09, expectations were $0.07. Operator: Good morning, ladies and gentlemen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback